Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Lord

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 17, 2008
2-Aryloxymethylmorpholine histamine H(3) antagonistsMichael A Letavic, John M Keith, Kiev S Ly, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 2, 2014
Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432Brian Lord, Leah Aluisio, James R Shoblock, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2015
A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effectsPascal Bonaventure, Sujin Yun, Philip L Johnson, et al.
European Journal of Pharmacology|May 24, 2008
In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitorLeah Aluisio, Brian Lord, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitorsJohn M Keith, Leslie A Gomez, Ronald L Wolin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 21, 2018
Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedoniaAnindya Bhattacharya, Brian Lord, Jan-Sebastian Grigoleit, et al.
British Journal of Pharmacology|July 30, 2013
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567Anindya Bhattacharya, Qi Wang, Hong Ao, et al.
European Journal of Pharmacology|April 10, 2019
Pharmacology of JNJ-28583113: A novel TRPM2 antagonistLawrence Fourgeaud, Curt Dvorak, Malika Faouzi, et al.
British Journal of Pharmacology|May 14, 2025
Pharmacological characterisation of JNJ-78911118, a novel, centrally-penetrant, selective GluN2A antagonistBrian Lord, Sirak Simavorian, Ian Fraser, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
1<i>H</i>-Pyrrolo[3,2-<i>b</i>]pyridine GluN2B-Selective Negative Allosteric ModulatorsChrista C Chrovian, Akinola Soyode-Johnson, Jessica L Wall, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|October 17, 2008
2-Aryloxymethylmorpholine histamine H(3) antagonistsMichael A Letavic, John M Keith, Kiev S Ly, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 2, 2014
Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432Brian Lord, Leah Aluisio, James R Shoblock, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2015
A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effectsPascal Bonaventure, Sujin Yun, Philip L Johnson, et al.
European Journal of Pharmacology|May 24, 2008
In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitorLeah Aluisio, Brian Lord, Ann J Barbier, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitorsJohn M Keith, Leslie A Gomez, Ronald L Wolin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 21, 2018
Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedoniaAnindya Bhattacharya, Brian Lord, Jan-Sebastian Grigoleit, et al.
British Journal of Pharmacology|July 30, 2013
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567Anindya Bhattacharya, Qi Wang, Hong Ao, et al.
European Journal of Pharmacology|April 10, 2019
Pharmacology of JNJ-28583113: A novel TRPM2 antagonistLawrence Fourgeaud, Curt Dvorak, Malika Faouzi, et al.
British Journal of Pharmacology|May 14, 2025
Pharmacological characterisation of JNJ-78911118, a novel, centrally-penetrant, selective GluN2A antagonistBrian Lord, Sirak Simavorian, Ian Fraser, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
1<i>H</i>-Pyrrolo[3,2-<i>b</i>]pyridine GluN2B-Selective Negative Allosteric ModulatorsChrista C Chrovian, Akinola Soyode-Johnson, Jessica L Wall, et al.
Pageof 7